The company plans to shut down the plant in May 2013 for a few weeks.
Lonza provides products and services covering research to final product manufacturing needs of the pharmaceutical, healthcare and life science industries.
The company’s products include chemical and biotech ingredients to the nutrition and agro markets besides large and small molecules, peptides, amino acids, niche bioproducts and so on.